^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

petosemtamab (MCLA-158)

i
Other names: MCLA-158, MCLA 158, MCLA158, LGR5 x EGFR Biclonics, Peto
Company:
Merus
Drug class:
EGFR antagonist, LGR5 inhibitor